Significant responses to platinum-based chemotherapy in renal medullary carcinoma
Article first published online: 15 DEC 2004
Copyright © 2004 Wiley-Liss, Inc.
Pediatric Blood & Cancer
Volume 44, Issue 4, pages 407–411, April 2005
How to Cite
Strouse, J. J., Spevak, M., Mack, A. K., Arceci, R. J., Small, D. and Loeb, D. M. (2005), Significant responses to platinum-based chemotherapy in renal medullary carcinoma. Pediatr. Blood Cancer, 44: 407–411. doi: 10.1002/pbc.20292
- Issue published online: 14 FEB 2005
- Article first published online: 15 DEC 2004
- Manuscript Accepted: 31 OCT 2004
- Manuscript Received: 30 JUN 2004
- renal medullary carcinoma;
- sickle cell trait
Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel. © 2004 Wiley-Liss, Inc.